LY-293284

From WikiMD's WELLNESSPEDIA

LY-293284 is a serotonin receptor agonist that was developed by Eli Lilly and Company. It is a potent and selective 5-HT1A receptor agonist, which has been used in scientific research to investigate the role of the 5-HT1A receptor in various processes.

History[edit]

LY-293284 was first synthesized by researchers at Eli Lilly and Company, a pharmaceutical company based in the United States. The compound was developed as part of the company's ongoing efforts to develop new treatments for neurological disorders and psychiatric disorders.

Pharmacology[edit]

LY-293284 is a potent and selective agonist for the 5-HT1A receptor, a type of serotonin receptor. Serotonin is a neurotransmitter that plays a key role in many different physiological processes, including mood regulation, appetite, sleep, and cognition. By activating the 5-HT1A receptor, LY-293284 can influence these processes.

Research[edit]

Research on LY-293284 has primarily focused on its potential use in the treatment of psychiatric disorders. In preclinical studies, the compound has been shown to have anxiolytic effects, suggesting that it could potentially be used to treat anxiety disorders. However, further research is needed to fully understand the therapeutic potential of LY-293284.

See also[edit]

This article is a stub related to pharmacology. You can help WikiMD by expanding it!


  • LY-293284
    LY-293284

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=LY-293284&oldid=6495234"